KalVista Pharmaceuticals announces six abstracts accepted for presentation at the 2024 Bradykinin Symposium

KalVista Pharmaceuticals today announced the acceptance of multiple abstracts at the 2024 Bradykinin Symposium taking place in Berlin, Germany on 5-6 September 2024.

The following presentations will take place on Friday 6 September in the Kaiserin Friedrich-Haus Lecture Hall:

Oral Presentations

  • Delayed On-demand Treatment of Hereditary Angioedema Attacks and Associated Barriers Reported by Italian patients: Mauro Cancian, Pietro Accardo, Francesco Arcoleo, Donatella Bignardi, Caterina Colangelo, Francesco Giardino, Antonio Gidaro, Marica Giliberti, Maria Domenica Guarino, Paola Lucia Minciullo, Stefania Nicola, Francesca Perego, Riccardo Senter, Giuseppe Spadaro, Paola Triggianese, Massimo Triggiani, Sherry Danese, Julie Ulloa, Vibha Desai, Tomas Andriotti, Paul Audhya, Andrea Zanichelli. Results shared in Session IV as an oral presentation and Q&A on Friday 6 September from 9:20 – 9:30 CET.
  • Pooled Sebetralstat Placebo-controlled Safety for On-demand Treatment of Hereditary Angioedema: Emel Aygören-Pürsün, Jonathan A. Bernstein, Danny Cohn, Henriette Farkas, William Lumry, Marc Riedl, Andrea Zanichelli, Samuel Owiredu-Yeboa, James Hao, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Marcus Maurer. Results shared in Session IV as an oral presentation and Q&A on Friday 6 September from 9:30 – 9:40 CET.
  • A Specific, Sensitivity Assay Measuring Patient Sample Plasma Kallikrein Activity: D. Lee, A. Ghannam, N. Murugesan, D. Vincent, A. Mogg, M. Smith, S. Hampton, E. Feener. Results shared in Session V as an oral presentation and Q&A on Friday 6 September from 11:50 – 12:00 CET.
  • KONFIDENT-S Interim Analysis: Sebetralstat for Hereditary Angioedema Attacks Including Laryngeal: Henriette Farkas, Marc A. Riedl, Emel Aygören-Pürsün, William R. Lumry, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Jonathan A. Bernstein, Marcus Maurer, Danny M. Cohn. Results shared in Session VI as an oral presentation and Q&A on Friday 6 September from 13:10 – 13:20 CET.

Poster Presentations

  • Pooled Sebetralstat Placebo-controlled Efficacy for On-demand Treatment of Hereditary Angioedema: Marcus Maurer, Jonathan A. Bernstein, Danny Cohn, Henriette Farkas, William Lumry, Marc Riedl, Andrea Zanichelli, James Hao, Matthew Iverson, Michael D. Smith, Christopher M. Yea, Paul K. Audhya, Emel Aygören-Pürsün. Results shared in a poster presentation and Q&A on Friday 6 September from 15:35 – 16:15 CET.
  • Phase 3 KONFIDENT Trial of Sebetralstat for HAE: European Subgroup: Andrea Zanichelli, Henriette Farkas, Emel Aygören-Pürsün, Fotios Psarros, Maria Staevska, Mauro Cancian, Sinisa Savic, Marcin Stobiecki, Eunice Dias de Castro, Marcin Kurowski, Ramon Lleonart, Vesna Panovska, Danny Cohn, Paul Audhya, Chris Yea, James Hao, Matthew Iverson, Michael Smith, Markus Magerl, Marcus Maurer. Results shared in a poster presentation and Q&A on Friday 6 September from 15:35 – 16:15 CET.

(Source: KalVista)